Designed zinc finger protein interacting with the HIV-1 integrase recognition sequence at 2-LTR-circle junctions.
Integration of HIV-1 cDNA into the host genome is a crucial step for viral propagation. Two nucleotides, cytosine and adenine (CA), conserved at the 3' end of the viral cDNA genome, are cleaved by the viral integrase (IN) enzyme. As IN plays a crucial role in the early stages of the HIV-1 life cycle, substrate blockage of IN is an attractive strategy for therapeutic interference. In this study, we used the 2-LTR-circle junctions of HIV-1 DNA as a model to design zinc finger protein (ZFP) targeting at the end terminal portion of HIV-1 LTR. A six-contiguous ZFP, namely 2LTRZFP was designed using zinc finger tools. The designed motif was expressed and purified from E. coli to determine its binding properties. Surface plasmon resonance (SPR) was used to determine the binding affinity of 2LTRZFP to its target DNA. The level of dissociation constant (K(d)) was 12.0 nM. The competitive SPR confirmed that 2LTRZFP specifically interacted with its target DNA. The qualitative binding activity was subsequently determined by EMSA and demonstrated the aforementioned correlation. In addition, molecular modeling and binding energy analyses were carried out to provide structural insight into the binding of 2LTRZFP to the specific and nonspecific DNA target. It is suggested that hydrogen-bonding interactions play a key role in the DNA recognition mechanisms of the designed ZFP. Our study suggested an alternative HIV therapeutic strategy using ZFP interference of the HIV integration process.
Sakkhachornphop
Supachai
S
Division of Clinical Immunology, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.
Jiranusornkul
Supat
S
Kodchakorn
Kanchanok
K
Nangola
Sawitree
S
Sirisanthana
Thira
T
Tayapiwatana
Chatchai
C
D000595:Amino Acid Sequence; D001483:Base Sequence; D003001:Cloning, Molecular; D004247:DNA / Q000737:chemistry / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D024202:Electrophoretic Mobility Shift Assay; D019427:HIV Integrase / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism; D016325:HIV Long Terminal Repeat / Q000235:genetics*; D015497:HIV-1 / Q000235:genetics*; D006367:HeLa Cells; D006801:Humans; D007700:Kinetics; D008954:Models, Biological; D008958:Models, Molecular; D008969:Molecular Sequence Data; D011485:Protein Binding / Q000235:genetics; D020349:Surface Plasmon Resonance; D013816:Thermodynamics; D016335:Zinc Fingers / Q000235:genetics*
D004268:DNA-Binding Proteins; D004247:DNA; D019427:HIV Integrase
Proteins. 1995 Sep;23(1):12-31
8539245
Biochemistry. 2003 Aug 5;42(30):9235-47
12885259
Nat Med. 2002 Dec;8(12):1427-32
12415262
Expert Opin Investig Drugs. 2008 Mar;17(3):413-22
18321239
J Biol Chem. 2001 Aug 3;276(31):29466-78
11340073
J Virol. 1990 Oct;64(10):4903-6
1697909
Trends Genet. 1993 Dec;9(12):433-8
8122311
J Virol. 1991 Oct;65(10):5624-30
1895409
J Virol. 1995 May;69(5):3233-6
7707558
J Virol. 1996 Dec;70(12):9069-73
8971046
J Biol Chem. 2005 Oct 21;280(42):35588-97
16107335
Cell. 1979 Feb;16(2):323-32
455438
Mol Pharmacol. 2004 Jan;65(1):85-98
14722240
Mol Pharmacol. 2004 Dec;66(6):1361-71
15340042
J Biol Chem. 2004 Apr 9;279(15):14509-19
14734553
Proc Natl Acad Sci U S A. 1975 Feb;72(2):447-51
1054828
Proc Natl Acad Sci U S A. 1981 Jan;78(1):124-8
6264426
Sci Am. 1988 Oct;259(4):82-9
3072675
J Virol. 1993 Mar;67(3):1169-74
8437208
J Mol Biol. 2000 Nov 3;303(4):489-502
11054286
Science. 1989 Aug 11;245(4918):635-7
2503871
J Virol. 1995 May;69(5):3216-9
7707554
J R Soc Interface. 2008 Dec 6;5 Suppl 3:S191-8
18782724
Nucleic Acids Res. 2009 Mar;37(4):1193-201
19129221
Science. 1991 May 10;252(5007):809-17
2028256
J Mol Biol. 2005 Apr 22;348(1):85-100
15808855
Proc Natl Acad Sci U S A. 1980 Jul;77(7):3932-6
6449003
J Mol Biol. 1976 Sep 15;106(2):337-57
185393
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1615-20
12574502
Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W516-23
16845061
EMBO J. 1985 Jun;4(6):1609-14
4040853
J HIV Ther. 2008 Jun;13(2):36-9
18953272
Structure. 1996 Oct 15;4(10):1171-80
8939742
HIV Med. 2008 Oct;9(9):765-70
18651855
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W526-31
15980527
J Virol. 1995 May;69(5):2729-36
7535863
J Virol. 2008 Aug;82(16):8013-21
18524822
Annu Rev Biochem. 1994;63:133-73
7526778
Methods Mol Biol. 1999;112:531-52
10027275
J Virol. 1977 Jan;21(1):119-30
556779
J Mol Biol. 2006 Oct 20;363(2):405-21
16963084
Nucleic Acids Res. 1997 Sep 1;25(17):3389-402
9254694
J Virol. 1994 Dec;68(12):7825-32
7966572
J Virol. 1978 Jan;25(1):104-4
202729
J Virol. 1991 Sep;65(9):4636-44
1870194
Curr Med Chem. 2001 Nov;8(13):1543-72
11562282
J Drug Target. 2007 Jan;15(1):21-36
17365271
J Virol. 1997 Feb;71(2):1025-35
8995622
J Comput Chem. 2003 Dec;24(16):1999-2012
14531054